1. Home
  2. ZEO vs MRKR Comparison

ZEO vs MRKR Comparison

Compare ZEO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • MRKR
  • Stock Information
  • Founded
  • ZEO 2005
  • MRKR N/A
  • Country
  • ZEO United States
  • MRKR United States
  • Employees
  • ZEO N/A
  • MRKR N/A
  • Industry
  • ZEO
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • MRKR Health Care
  • Exchange
  • ZEO NYSE
  • MRKR Nasdaq
  • Market Cap
  • ZEO 25.7M
  • MRKR 30.7M
  • IPO Year
  • ZEO N/A
  • MRKR N/A
  • Fundamental
  • Price
  • ZEO $1.78
  • MRKR $4.03
  • Analyst Decision
  • ZEO
  • MRKR Strong Buy
  • Analyst Count
  • ZEO 0
  • MRKR 1
  • Target Price
  • ZEO N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • ZEO 2.7M
  • MRKR 85.1K
  • Earning Date
  • ZEO 12-31-2024
  • MRKR 11-14-2024
  • Dividend Yield
  • ZEO N/A
  • MRKR N/A
  • EPS Growth
  • ZEO N/A
  • MRKR N/A
  • EPS
  • ZEO 0.67
  • MRKR N/A
  • Revenue
  • ZEO $95,455,763.00
  • MRKR $5,395,849.00
  • Revenue This Year
  • ZEO N/A
  • MRKR $35.94
  • Revenue Next Year
  • ZEO N/A
  • MRKR N/A
  • P/E Ratio
  • ZEO $2.78
  • MRKR N/A
  • Revenue Growth
  • ZEO N/A
  • MRKR 79.04
  • 52 Week Low
  • ZEO $1.05
  • MRKR $2.44
  • 52 Week High
  • ZEO $11.60
  • MRKR $6.16
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 49.38
  • MRKR 52.95
  • Support Level
  • ZEO $1.27
  • MRKR $3.36
  • Resistance Level
  • ZEO $3.05
  • MRKR $5.95
  • Average True Range (ATR)
  • ZEO 0.40
  • MRKR 0.60
  • MACD
  • ZEO 0.01
  • MRKR 0.09
  • Stochastic Oscillator
  • ZEO 29.44
  • MRKR 28.89

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: